- Do gonadotropin-releasing hormone antagonists have a lower risk of ca…
Number of the records: 1  

Do gonadotropin-releasing hormone antagonists have a lower risk of cardiovascular complications in comparison to agonists?

  1. TitleDo gonadotropin-releasing hormone antagonists have a lower risk of cardiovascular complications in comparison to agonists? = Pôsobia antagonisty gonadoliberínu menej negatívne na kardiovaskulárny systém v porovnaní s agonistami? / Valášková Z. ... [et al.]
    Another responsib. Valášková Poljak, Zuzana (Author)
    Hulín, Ivan, 1938- (Author)
    Fillo, Juraj (Author)
    El-Hassoun, Olia Hussein Jamil (Author)
    Mladosievičová, Beata (Author)
    Phys.des.ilustr., tab.
    Par.titlePôsobia antagonisty gonadoliberínu menej negatívne na kardiovaskulárny systém v porovnaní s agonistami?
    NoteBibliogr. odkazy. Res. angl., slov.
    In Cardiology letters. -- ISSN 1338-3655. -- Vol. 27, no. 5 (2018), s. 242-248
    Call numberC 2635
    MeSH Subject hormón uvoľňujúci gonadotropín - agonisty
    hormón uvoľňujúci gonadotropín - antagonisty a inhibítory
    kardiotoxicita
    folikuly stimulujúci hormón
    hormón uvoľňujúci gonadotropín
    Keywords terapia androgén-deprivačná (ADT) * riziko kardiovaskulárne * gonadoliberín
    LanguageSlovak
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.